Steve Holmes Patient Survivor: 14000 kilometre Cycling Circumnavigation of Australia By Steve|2024-10-13T19:18:49+10:00September 16th, 2024|Categories: All, Patient Story, Z-Legacy|Tags: Cholangio Challenger, Steve Holmes| Read More 0
The Checkpoint Pathway: Ipilimumab and Keytruda immunotherapy combination By Steve|2024-10-13T19:18:51+10:00September 15th, 2024|Categories: All, Treatments, Z-Legacy|Tags: Ipilum| Read More 0
Understanding BRCA1 and BRCA2 in Cholangiocarcinoma By Steve|2024-10-13T19:18:54+10:00August 10th, 2024|Categories: All, Genes, Z-Legacy|Tags: BAP1, BRCA1, BRCA2, Clinical Trial| Read More 0
Exploring the TAS-120-205 Trial: Understanding FGFR2 Inhibitor Impact on Cholangiocarcinoma Treatment” By Steve|2024-12-14T10:15:10+10:00July 31st, 2024|Categories: Z-Legacy|Tags: 120-205, Clinical Trial, FGFR2, TAS, Tiaho| Read More 0
Bile Gone Bad-Article 3: Understanding Bile Duct Damage and Bile Duct Cancers By Steve|2024-10-13T19:18:57+10:00July 21st, 2024|Categories: All, Bile Gone Bad, Investigative, Z-Legacy|Tags: Bile Gone Bad| Read More 0
Meet GEM/CIS/DURVA: A Formidable Trio in the Fight Against Cancer By Steve|2024-10-13T19:18:59+10:00July 18th, 2024|Categories: All, Treatments, Trials & Studies, Z-Legacy|Tags: durvalumab, Gem/Cis/Durva| Read More 0
Silent Chronic Inflammation and Rising Cholangiocarcinoma, Especially in Younger Patients By Steve|2024-10-13T19:19:01+10:00July 17th, 2024|Categories: All, Bile Gone Bad, Z-Legacy|Tags: Bile Gone Bad| Read More 0
Bile Gone Bad: The Rising Incidence of Bile Duct Cancer – The Hidden Dangers within Bile Composition By Steve|2024-10-13T19:19:03+10:00July 9th, 2024|Categories: All, Trials & Studies, Z-Legacy|Tags: Bile Gone Bad| Read More 0
Unlocking the Power of Immunotherapy and Gem/Cis: A Strategic Battle Plan for Fighting Cholangiocarcinoma By Steve|2024-10-13T19:19:05+10:00July 8th, 2024|Categories: All, Drug Reviews, Trials & Studies, Z-Legacy|Tags: Gem/Cis/Durva, Gem/Cis/Keytruda| Read More 0
Meet Olaparib: A Key Player in the Fight Against Cancer By Steve|2024-10-13T19:19:08+10:00July 2nd, 2024|Categories: All, Drug Reviews, Z-Legacy|Tags: olaparib, PARP Inhibitor| Read More 0